Vico Therapeutics
Leiden
About Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarily affecting girls that enable clients with providing therapy for it.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $115.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2024)
- Website: vicotx.com
- Phone: +31 71 2036800
Industries & Categories
Health Care, Medical, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vico-therapeutics-55232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.